Increasing ESKD in Diabetes in the Land Down Under: What Can Be Done, We Must Wonder

Globally, kidney disease in diabetes is the leading cause of end-stage kidney disease (ESKD) and is associated with increased morbidity and mortality due to cardiovascular complications. Since 1990, national registries such as the US Renal Data System have provided data on the alarming increases in the number of people treated for ESKD due to diabetes.1 This has been partly due to the increasing number of individuals with type 1 and, in particular, type 2 diabetes. The number of people around the world with diabetes was estimated to be 415 million in 2015 and is expected to grow to more than 640 million people by 2040, according to the International Diabetes Federation.

http://bit.ly/2U6Monh